MLSS Quote, Financials, Valuation and Earnings

Envista Holdings Corp. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of -4.52%. Milestone Scientific, Inc.'s return on equity of -142.42% beat Envista Holdings Corp.'s return on equity of 0.5%.

Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 190.44%. On the other hand Envista Holdings Corp. has an analysts' consensus of $22.00 which suggests that it could grow by 7.58%. Given that Milestone Scientific, Inc. has higher upside potential than Envista Holdings Corp., analysts believe Milestone Scientific, Inc. is more attractive than Envista Holdings Corp..

Milestone Scientific, Inc. has a beta of 0.937, which suggesting that the stock is 6.331% less volatile than S&P 500. In comparison Envista Holdings Corp. has a beta of 1.025, suggesting its more volatile than the S&P 500 by 2.453%.

Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Envista Holdings Corp. pays out -- of its earnings as a dividend.

Milestone Scientific, Inc. quarterly revenues are $2.4M, which are smaller than Envista Holdings Corp. quarterly revenues of $669.9M. Milestone Scientific, Inc.'s net income of -$1.2M is higher than Envista Holdings Corp.'s net income of -$30.3M. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Envista Holdings Corp.'s PE ratio is 244.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 3.13x versus 1.33x for Envista Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Phibro Animal Health Corp. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of 7.29%. Milestone Scientific, Inc.'s return on equity of -142.42% beat Phibro Animal Health Corp.'s return on equity of 24.77%.

Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 190.44%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 3.89%. Given that Milestone Scientific, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe Milestone Scientific, Inc. is more attractive than Phibro Animal Health Corp..

Milestone Scientific, Inc. has a beta of 0.937, which suggesting that the stock is 6.331% less volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.

Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.16% to investors and pays a quarterly dividend of $0.12 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Milestone Scientific, Inc. quarterly revenues are $2.4M, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. Milestone Scientific, Inc.'s net income of -$1.2M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Phibro Animal Health Corp.'s PE ratio is 24.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 3.13x versus 1.21x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Solventum Corp. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of 60.4%. Milestone Scientific, Inc.'s return on equity of -142.42% beat Solventum Corp.'s return on equity of 42.2%.

Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 190.44%. On the other hand Solventum Corp. has an analysts' consensus of $84.36 which suggests that it could fall by -1.04%. Given that Milestone Scientific, Inc. has higher upside potential than Solventum Corp., analysts believe Milestone Scientific, Inc. is more attractive than Solventum Corp..

Milestone Scientific, Inc. has a beta of 0.937, which suggesting that the stock is 6.331% less volatile than S&P 500. In comparison Solventum Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solventum Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Solventum Corp. pays out -- of its earnings as a dividend.

Milestone Scientific, Inc. quarterly revenues are $2.4M, which are smaller than Solventum Corp. quarterly revenues of $2.1B. Milestone Scientific, Inc.'s net income of -$1.2M is lower than Solventum Corp.'s net income of $1.3B. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Solventum Corp.'s PE ratio is 9.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 3.13x versus 1.77x for Solventum Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona, Inc. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of -47.35%. Milestone Scientific, Inc.'s return on equity of -142.42% beat Dentsply Sirona, Inc.'s return on equity of -44.58%.

Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 190.44%. On the other hand Dentsply Sirona, Inc. has an analysts' consensus of $12.96 which suggests that it could grow by 14.37%. Given that Milestone Scientific, Inc. has higher upside potential than Dentsply Sirona, Inc., analysts believe Milestone Scientific, Inc. is more attractive than Dentsply Sirona, Inc..

Milestone Scientific, Inc. has a beta of 0.937, which suggesting that the stock is 6.331% less volatile than S&P 500. In comparison Dentsply Sirona, Inc. has a beta of 1.008, suggesting its more volatile than the S&P 500 by 0.82100000000001%.

Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona, Inc. offers a yield of 5.65% to investors and pays a quarterly dividend of $0.16 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Dentsply Sirona, Inc. pays out 13.85% of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Milestone Scientific, Inc. quarterly revenues are $2.4M, which are smaller than Dentsply Sirona, Inc. quarterly revenues of $904M. Milestone Scientific, Inc.'s net income of -$1.2M is higher than Dentsply Sirona, Inc.'s net income of -$428M. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Dentsply Sirona, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 3.13x versus 0.62x for Dentsply Sirona, Inc.. Usually stocks with elevated PS ratios are considered overvalued.